Sclavos S.A.
Sclavos S.A.
🇬🇷 Greece, Central Greece
194851-100 peopleManufacturerSclavos S.A. is a premier Greek industrial manufacturer specializing in the design and production of high-end textile dyeing machinery. Established in 1948 and headquartered in Schimatari, Greece, the company has built a global reputation for innovation in fabric dyeing technology. Operating as an OEM with a dedicated factory, Sclavos employs between 51 and 100 professionals and maintains ISO 9001 certification for its quality management systems.
The company is 100% dedicated to fabric dyeing solutions, most notably through its flagship Athena series, which includes models such as the Athena4A, Athena S2, and Athena4A-Hb. These machines incorporate advanced technical features like the Double Soft Floating dyeing system and the Aquachron FLX continuous washing system, designed to optimize efficiency and fabric quality. Their product portfolio also extends to stainless steel winches for knitted fabrics, industrial boilers, and specialized textile finishing machinery.
Sclavos serves a prestigious international clientele, including major industry players such as KAHATEX, DBL Group, Arvind, and Hayleys Group. With a strong export presence across North America, Europe, and Asia, the company facilitates global distribution through a network of local representatives. Under the leadership of CEO Aris Georgantas, Sclavos continues to provide the garment and textile industry with specialized machinery, parts, and attachments that meet rigorous industrial standards.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Established brandFounded in 1948, with over 20 years of industry experience.
Eco-friendly supplierUses sustainable and eco-friendly materials.
Experienced exporterHas extensive experience in global trade.
Contact
***************
*************
Customers
FAKIR FASHION
********************************
*******************
******
*************
Unlock all 102 customers
Certifications
ISO 90011
Ask AI about this supplier
Key export market
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Sanofi Vietnam Shareholding Company
🇻🇳 Vietnam
501-1000 peopleManufacturer/Trading CompanyHigh capacity factory
Own brand
Patented technology
Industry association member
Shipments
1334
Key customer
OPELLA
Key market
🇵🇭 Philippines
Description
Sanofi Vietnam Shareholding Company is a leading pharmaceutical manufacturer and trading entity based in Ho Chi Minh City, operating as a subsidiary of the French global healthcare group Sanofi. With over 70 years of presence in Vietnam, the company employs between 500 and 1,000 professionals and operates a state-of-the-art factory in the Saigon Hi-Tech Park. The facility is highly certified, holding TGA-GMP, WHO-GMP, and EU-GMP standards, and the company is recognized as a B Corp certified organization. Sanofi Vietnam specializes in a diverse healthcare portfolio including vaccines, general medicines, and consumer healthcare products such as vitamins, minerals, and supplements (VMS). Their extensive product range covers therapeutic areas such as cardiology, oncology, digestive health, and infectious diseases, featuring well-known brands like Calcium Corbiere, Enterogermina, and Lactacyd. As a key player in the regional market, the company provides contract manufacturing and OEM services, leveraging its Research and Development Centre to drive innovation. Sanofi Vietnam is also a significant international trader, managing a high volume of import and export shipments of pharmaceutical ingredients, biologicals, and specialized medical equipment like HPLC columns. Recent strategic partnerships have further expanded their capabilities into the local production of essential vaccines and biologicals, reinforcing their commitment to national health security and the broader Southeast Asian market.
Enoxaparin sodium Impact
Dulcoflex® 5mg Tablets
vaccine
Pharmaceutical Products
vaccines
From Molecule to Medicine: Journey Through CMC Development l Sanofi
Plavix
Imexpharm Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
19771001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
4
Key customer
BURYAT OMBOL
Key market
Europe
Description
Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide.
Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions.
As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.
Thực Phẩm Bảo Vệ Sức Khỏe
Vitamin & khoáng chất
Nhóm dùng ngoài
Diệt trừ ký sinh trùng
Tiểu đường
Tiêu hóa gan mật
Giãn mạch ngoại biên và hoạt hóa não
Kháng Histamin & Kháng dị ứng
Hệ hô hấp
Giảm đau - kháng viêm - hạ sốt
Cơ xương khớp
Mắt